EODData

MEMBERSHIP REGISTER LOG IN

OTCBB, GNIIF: Gni Group Ltd

10 Oct 2025
LAST:

15.95

CHANGE:
 3.93		OPEN:
15.95		HIGH:
15.95		ASK:
0.00		VOLUME:
100
CHG(%):
32.70		PREV:
12.02		LOW:
15.95		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume

COMPANY PROFILE

Name:Gni Group Ltd
About:GNI Group Ltd. engages in the research, development, manufacture, and sale of pharmaceutical drugs in Japan and internationally. The company offers Etuary for the treatment of idiopathic pulmonary fibrosis. It also developing Etuary, which is in Phase III clinical trial for the treatment of connective tissue associated interstitial lung disease; and in clinical trial pre-phase III clinical trial pilot study for the treatment of radiation pneumonitis, as well as for the treatment of diabetic nephropathy. In addition, the company involved in developing F351, which is in Phase III clinical trial for the treatment of liver fibrosis; and F573 that is in phase II for the treatment of acute on chronic liver failure, as well as Tamibarotene for the treatment of acute promyelocytic leukemia. GNI Group Ltd. was incorporated in 2001 and is headquartered in Tokyo, Japan.
Sector:Healthcare
Industry:Biotechnology
Address:Nihonbashi-Honcho YS Building, Tokyo, Japan, 103-0023
Website:https://www.gnipharma.com
CIK:0001958461
FIGI:BBG00F6JKC36

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

TECHNICAL INDICATORS

MA5:16.704.7%
Week High:15.950.0%
Week Low:15.950.0%